Unibest 优贝德
← 返回专利悬崖列表

CAS 2043-61-0

cyclohexanecarbaldehyde

登记编号:CICL-004

应用背景(按来源药适应症)

哮喘环索奈德常年性变应性鼻炎环索奈德季节性过敏性鼻炎环索奈德过敏性鼻炎环索奈德支气管肺发育不良环索奈德新型冠状病毒感染环索奈德

来源药(使用该中间体的合成路线)

品种梯队到期年
环索奈德CiclesonideTier C · 观察 / 贸易-

合成路线中的位置(上下游链)

按路线登记顺序排列,左→右为合成方向;高亮为当前 CAS,其余可点击跳转对应档案。

环索奈德优化路线步数:2总收率:18 g
cyclohexanecarbaldehyde→(8S,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-13-methyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one→(6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-8b-(2-bromoacetyl)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one→sodium isobutyrate
环索奈德优化路线步数:3总收率:/
cyclohexanecarbaldehyde→(6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one→(8S,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-13-methyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one→sodium cyclohexyl(hydroxy)methanesulfonate→isobutyryl chloride

本站可供应的对应中间体

目录暂未收录该靶点的在售中间体 —— 可直接发起询价,需求会进入撮合池。

本页为中间体 CAS 注册档案:同 CAS 的多条路线登记已合并;后续供应商报价与买方需求以该 CAS 为主键撮合。